Eli Lilly and Co (LLY)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$823.43
Buy
$826.00
$29.52 (+3.72%)
Prices updated at 03 May 2025, 00:37 EDT
| Prices minimum 15 mins delay
Prices in USD
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
---|---|
2024 | 81.31 |
2023 | 79.25 |
2022 | 76.77 |
2021 | 74.18 |
2020 | 77.66 |
2019 | 78.85 |
2018 | 78.22 |
2017 | 77.73 |
2016 | 73.09 |
Valuation data table
Year | Price / Sales |
---|---|
2025 | 14.64 |
2024 | 17.08 |
2023 | 17.25 |
2022 | 11.36 |
2021 | 9.08 |
2020 | 6.64 |
2019 | 5.08 |
2018 | 4.95 |
2017 | 3.98 |
2016 | 3.75 |
2015 | 4.57 |
Price/Forward earnings (YTD)
35.34
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
---|---|
2024 | 14.84 |
2023 | 9.23 |
2022 | 12.71 |
2021 | 11.70 |
2020 | 14.42 |
2019 | 20.00 |
2018 | 7.27 |
2017 | -0.49 |
2016 | 7.36 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 5.55 |
2023 | 5.94 |
2022 | 4.65 |
2021 | 5.44 |
2020 | 8.27 |
2019 | 15.07 |
2018 | 4.47 |
2017 | 3.88 |
2016 | 2.77 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.